🏥 Health 1d ago

Safety of Controversial Vasculitis Drug Bolstered in Dedicated Trial

MedPage Today
Medical news for professionals
View Channel →
Safety of Controversial Vasculitis Drug Bolstered in Dedicated Trial
Source ↗ 👁 0 💬 0
(MedPage Today) -- ORLANDO -- Interim results from a prospective trial designed to evaluate safety of avacopan (Tavneos), the embattled drug for antineutrophil cytoplasmic antibody-associated vasculitis (AAV), indicated that the product could...

Comments (0)

Sign in to join the discussion

More Like This

STAT+: Ionis Pharmaceuticals shares plummet after slow rollout of biotech’s triglyceride-lowering drug
STAT · 23h ago
Common Antibiotic Tied to Pregnancy Loss Risk
MedPageToday.com - medical news for physicians · 1d ago
Smartwatch Detection of Reduced LVEF? Not So Fast, Study Says.
MedPageToday.com - medical news for physicians · 1d ago
Police Investigate After 25 Half-Marathon Runners Seek Medical Care
MedPageToday.com - medical news for physicians · 1d ago
📰
DAISY Award spotlight: ‘She turned the most painful day of our lives into ones filled with love, honor, and peace for our baby boy.’
Vanderbilt Health News · 1d ago
Early Response to MASH Drug Linked to Resolution, Fibrosis Improvement
MedPageToday.com - medical news for physicians · 1d ago